Determinants of Plaque Progression Despite Very Low Low-Density Lipoprotein–Cholesterol Levels With the PCSK9 Inhibitor, Evolocumab

Satoshi Honda, Rishi Puri, Todd Anderson, John J. P. Kastelein, Danielle M. Brennan, Helina Kassahun, Ransi Somaratne, Scott M. Wasserman, Steve E. Nissen, Stephen J. Nicholls

Research output: Contribution to journalComment/Letter to the editorAcademic

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)709-711
Number of pages3
JournalJACC. Cardiovascular imaging
Issue number4
Publication statusPublished - 1 Apr 2022

Cite this